JBIO financials

Jade Biosciences (JBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

JBIO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$113.54M-$100.14M-0.35
2024––-$74.60M-$69.63M-2.44
2023––-$81.41M-$75.52M-2.87
2022––-$53.24M-$51.51M-2.10
2021––-$23.02M-$22.98M-1.87
2020––-$8.89M-$9.76M-40.31